Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-12-13 Purchase | 2024-12-16 08:05 am | Phathom Pharmaceuticals Inc. | PHAT | KARBE FRANK Director | 12,500 | $7.9267 | $99,084 | 57,000 (Direct) | View |
| 2023-07-27 Purchase | 2023-07-31 07:58 am | Better Therapeutics Inc. | BTTX | KARBE FRANK Chief Executive Officer | 137,005 | $0.7299 | $100,000 | 429,429 (Direct) | View |
| 2023-04-10 Purchase | 2023-04-12 4:15 pm | Better Therapeutics Inc. | BTTX | KARBE FRANK See Remarks | 242,424 | $0.825 | $200,000 | 292,424 (Direct) | View |
| 2022-09-15 Purchase | 2022-09-15 8:53 pm | Better Therapeutics Inc. | BTTX | KARBE FRANK See Remarks | 50,000 | $2.0939 | $104,695 | 50,000 (Direct) | View |
| 2021-07-07 Sale | 2021-07-09 4:27 pm | Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting | 3,232 | $21.75 | $70,296 | 212,296 (Direct) | View |
| 2021-04-06 Sale | 2021-04-08 4:55 pm | Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting | 11,080 | $18.63 | $206,420 | 152,390 (Direct) | View |
| 2021-02-16 Sale | 2021-02-18 4:52 pm | Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting | 750 | $21.4 | $16,050 | 345,214 (Direct) | View |
| 2021-01-28 Sale | 2021-02-01 4:29 pm | Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting | 300 | $24 | $7,200 | 345,964 (Direct) | View |
| 2021-01-15 Sale | 2021-01-20 4:39 pm | Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting | 750 | $21.5 | $16,125 | 346,264 (Direct) | View |
| 2020-12-28 Sale | 2020-12-30 4:29 pm | Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting | 11,800 | $30 | $354,000 | 347,014 (Direct) | View |
| 2020-12-15 Sale | 2020-12-17 4:51 pm | Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting | 1,050 | $24.15 | $25,363 | 358,814 (Direct) | View |
| 2020-11-30 Sale | 2020-12-02 5:08 pm | Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting | 1,500 | $24 | $36,000 | 359,864 (Direct) | View |
| 2020-11-17 Sale | 2020-11-19 5:04 pm | Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting | 750 | $20 | $15,000 | 361,364 (Direct) | View |
| 2020-11-13 Sale | 2020-11-17 6:50 pm | Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting | 750 | $20 | $15,000 | 362,114 (Direct) | View |
| 2020-09-15 Sale | 2020-09-17 4:20 pm | Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting | 750 | $21.73 | $16,298 | 362,864 (Direct) | View |
| 2020-08-28 Sale | 2020-09-01 4:37 pm | Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting | 24,800 | $20.02 | $496,421 | 584,908 (Direct) | View |
| 2020-08-19 Sale | 2020-08-21 5:07 pm | Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting | 700 | $20 | $14,000 | 388,414 (Direct) | View |
| 2019-12-30 Sale | 2019-12-30 7:13 pm | Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting | 19,701 | $15.55 | $306,351 | 43,324 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-05-29 Option Award | 2024-05-31 4:30 pm | N/A N/A | Phathom Pharmaceuticals Inc. | PHAT | KARBE FRANK Director | 25,000 | $10.16 | 44,500 (Direct) | View |
| 2024-05-23 Option Award | 2024-05-24 7:33 pm | N/A 2034-05-22 | Phathom Pharmaceuticals Inc. | PHAT | KARBE FRANK Director | 28,000 | $0 | 37,000 (Direct) | View |
| 2023-12-18 Option Award | 2023-12-20 5:13 pm | N/A N/A | Better Therapeutics Inc. | BTTX | KARBE FRANK Chief Executive Officer | 62,500 | $0 | 526,516 (Direct) | View |
| 2023-05-25 Option Award | 2023-05-30 6:48 pm | N/A 2033-05-24 | Phathom Pharmaceuticals Inc. | PHAT | KARBE FRANK Director | 24,000 | $0 | 24,000 (Direct) | View |
| 2022-07-05 Option Award | 2022-07-07 4:32 pm | N/A 2032-07-04 | Better Therapeutics Inc. | BTTX | KARBE FRANK See Remarks | 472,200 | $0 | 472,200 (Direct) | View |
| 2022-05-25 Option Award | 2022-05-27 4:41 pm | N/A 2032-05-24 | Phathom Pharmaceuticals Inc. | PHAT | KARBE FRANK Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2022-04-25 Option Award | 2022-04-26 5:21 pm | N/A 2032-04-24 | Phathom Pharmaceuticals Inc. | PHAT | KARBE FRANK Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2021-04-15 Option Award | 2021-04-19 4:17 pm | N/A 2031-04-14 | Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting | 160,672 | $0 | 313,062 (Direct) | View |
| 2021-02-16 Exercise | 2021-02-18 4:52 pm | N/A N/A | Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting | 750 | $5.11 | 345,214 (Direct) | View |
| 2021-02-16 Exercise | 2021-02-18 4:52 pm | N/A 2026-09-20 | Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting | 750 | $0 | 345,214 (Direct) | View |
| 2021-01-28 Exercise | 2021-02-01 4:29 pm | N/A N/A | Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting | 300 | $5.11 | 345,964 (Direct) | View |
| 2021-01-28 Exercise | 2021-02-01 4:29 pm | N/A 2026-09-20 | Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting | 300 | $0 | 345,964 (Direct) | View |
| 2021-01-15 Exercise | 2021-01-20 4:39 pm | N/A N/A | Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting | 750 | $5.11 | 346,264 (Direct) | View |
| 2021-01-15 Exercise | 2021-01-20 4:39 pm | N/A 2026-09-20 | Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting | 750 | $0 | 346,264 (Direct) | View |
| 2020-12-28 Exercise | 2020-12-30 4:29 pm | N/A N/A | Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting | 11,800 | $5.11 | 347,014 (Direct) | View |
| 2020-12-28 Exercise | 2020-12-30 4:29 pm | N/A 2026-09-20 | Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting | 11,800 | $0 | 347,014 (Direct) | View |
| 2020-12-15 Exercise | 2020-12-17 4:51 pm | N/A N/A | Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting | 1,050 | $5.11 | 358,814 (Direct) | View |
| 2020-12-15 Exercise | 2020-12-17 4:51 pm | N/A 2026-09-20 | Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting | 1,050 | $0 | 358,814 (Direct) | View |
| 2020-11-30 Exercise | 2020-12-02 5:08 pm | N/A N/A | Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting | 1,500 | $5.11 | 359,864 (Direct) | View |
| 2020-11-30 Exercise | 2020-12-02 5:08 pm | N/A 2026-09-20 | Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting | 1,500 | $0 | 359,864 (Direct) | View |
| 2020-11-17 Exercise | 2020-11-19 5:04 pm | N/A N/A | Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting | 750 | $5.11 | 361,364 (Direct) | View |
| 2020-11-17 Exercise | 2020-11-19 5:04 pm | N/A 2026-09-20 | Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting | 750 | $0 | 361,364 (Direct) | View |
| 2020-11-13 Exercise | 2020-11-17 6:50 pm | N/A N/A | Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting | 750 | $5.11 | 362,114 (Direct) | View |
| 2020-11-13 Exercise | 2020-11-17 6:50 pm | N/A 2026-09-20 | Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting | 750 | $0 | 362,114 (Direct) | View |
| 2020-09-15 Exercise | 2020-09-17 4:20 pm | N/A N/A | Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting | 750 | $5.11 | 362,864 (Direct) | View |
| 2020-09-15 Exercise | 2020-09-17 4:20 pm | N/A 2026-09-20 | Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting | 750 | $0 | 362,864 (Direct) | View |
| 2020-08-28 Exercise | 2020-09-01 4:37 pm | N/A N/A | Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting | 24,800 | $5.11 | 584,908 (Direct) | View |
| 2020-08-28 Exercise | 2020-09-01 4:37 pm | N/A 2026-09-20 | Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting | 24,800 | $0 | 584,908 (Direct) | View |
| 2020-08-19 Exercise | 2020-08-21 5:07 pm | N/A N/A | Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting | 700 | $5.11 | 388,414 (Direct) | View |
| 2020-08-19 Exercise | 2020-08-21 5:07 pm | N/A 2026-09-20 | Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting | 700 | $0 | 388,414 (Direct) | View |
| 2020-05-05 Option Award | 2020-05-28 8:00 pm | N/A 2030-05-04 | ADURO BIOTECH INC. | ADRO | KARBE FRANK Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2020-04-03 Option Award | 2020-04-07 5:10 pm | N/A 2030-04-02 | Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting | 304,137 | $0 | 347,461 (Direct) | View |